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Objective
To evaluate the enhancement of aqueous solubility of
a poorly water soluble drug ritonavir by forming its
complex with a phospholipid (Phospholipon® 90H).
Methods
The ritonavir-phospholipid complex (RPC) was
prepared using a modified solvent evaporation method.
A circumscribed central composite design, as shown in
table 1, was used to analyze, and optimize the
formulation and the process variables to obtain
acceptable ritonavir-phospholipid complex (RPC). The
influence of phospholipid-to-drug ratio (X1, w:w),
reaction temperature (X2, °C) and the reaction time (X3,
h) on the entrapment efficiency of ritonavir in RPC were
evaluated. The prepared RPC was then characterized by
Fourier Transformed Infrared (FTIR) Spectroscopy,
Differential Scanning Calorimetry (DSC), Powder X-Ray
Diffraction (PXRD), and Scanning Electron Microscopy
(SEM). Additionally, the RPC was evaluated for apparent
aqueous solubility, and the release of ritonavir in-vitro.

Table 1:
Coded levels and “Real” values for each variable studied
Factors
Phospholipid: drug ratio
(X1, w:w)
Reaction temperature
(X2, °C)
Reaction time (X3, h)

-1.732

-1

Levels
0

0.5

1.01

1.75

1.41

2

40
1

44.05

50

Table 2:
Apparent aqueous solubility of the samples

+1

+1.732

2.49

3.0

2.59

3

55.95

60

Sample

Aqueous solubility (µg/ml)*
Ritonavir
0.41 ± 0.04
Physical Mixture
2.09 ± 0.35
RPC
15.73 ± 0.59
* Data expressed as mean ± Std. Dev., n = 3

Results
The RPC, with an entrapment efficiency of over 90%
w/w, was successfully prepared. The optimum
conditions identified to obtain a high efficiency RPC
were, phospholipid-to-drug ratio of 1.75:1, the reaction
temperature of 50°C, and a reaction time of 3 hours. The
FTIR, DSC, and the PXRD data confirmed the formation
of a complex between ritonavir and Phospholipon® 90H.
The SEM images indicated that RPC was composed of
irregular size vesicles of hydrogenated soy
phosphatidylcholine, and ritonavir intercalated in the
lipid layers.

Results (contd.)
The apparent aqueous solubility of ritonavir, the
physical mixture of ritonavir with Phospholipon® 90H,
and the RPC are shown in table 2.
The results showed that formulation of RPC
significantly increased the aqueous solubility of
ritonavir. Additionally, the in-vitro dissolution results
showed that, at the end of 10 hours, free ritonavir
showed 32.47% release; whereas, the drug release from
RPC was 99.61%.
This increase in the solubility and the dissolution
characteristics of the complex may be explained by the
amphiphilic nature of the complex, as well as possible
amorphization of the drug by the phospholipid.
Conclusions
The prepared RPC showed a significant (~30-fold)
enhancement in the apparent aqueous solubility, as well
as the dissolution behavior of ritonavir. Drugphospholipid complexes can serve as potential
alternative strategy for enhancing the aqueous solubility
of poorly water soluble drugs such as ritonavir.

